ArticleJournal of neuro-oncology2024

Response to correspondence on an exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma.

Toshihide Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.